Precision mouse models of Yars/dominant intermediate Charcot-Marie-Tooth disease type C and Sptlc1/hereditary sensory and autonomic neuropathy type 1

被引:11
|
作者
Hines, Timothy J. [1 ]
Tadenev, Abigail L. D. [1 ]
Lone, Museer A. [2 ]
Hatton, Courtney L. [1 ]
Bagasrawala, Inseyah [1 ]
Stum, Morgane G. [1 ]
Miers, Kathy E. [1 ]
Hornemann, Thorsten [2 ]
Burgess, Robert W. [1 ]
机构
[1] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA
[2] Univ Zurich, Inst Clin Chem, Zurich, Switzerland
基金
瑞士国家科学基金会; 美国国家卫生研究院;
关键词
axon degeneration; Charcot-Marie-Tooth; demyelination; HSN1; inherited peripheral neuropathy; sphingolipid synthesis; SPTLC2; tRNA synthetase; YARS; TRANSFER-RNA SYNTHETASE; SERINE PALMITOYLTRANSFERASE; MUTATIONS; SUBUNIT; SPTLC1; ACCUMULATION; TRANSFERASE; EXPRESSION; PHENOTYPE; CELLS;
D O I
10.1111/joa.13605
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Animal models of neurodegenerative diseases such as inherited peripheral neuropathies sometimes accurately recreate the pathophysiology of the human disease, and sometimes accurately recreate the genetic perturbations found in patients. Ideally, models achieve both, but this is not always possible; nonetheless, such models are informative. Here we describe two animal models of inherited peripheral neuropathy: mice with a mutation in tyrosyl tRNA-synthetase, Yars(E196K), modeling dominant intermediate Charcot-Marie-Tooth disease type C (diCMTC), and mice with a mutation in serine palmitoyltransferase long chain 1, Sptlc1(C133W), modeling hereditary sensory and autonomic neuropathy type 1 (HSAN1). Yars(E196K) mice develop disease-relevant phenotypes including reduced motor performance and reduced nerve conduction velocities by 4 months of age. Peripheral motor axons are reduced in size, but there is no reduction in axon number and plasma neurofilament light chain levels are not increased. Unlike the dominant human mutations, the Yars(E196K) mice only show these phenotypes as homozygotes, or as compound heterozygotes with a null allele, and no phenotype is observed in E196K or null heterozygotes. The Sptlc1(C133W) mice carry a knockin allele and show the anticipated increase in 1-deoxysphingolipids in circulation and in a variety of tissues. They also have mild behavioral defects consistent with HSAN1, but do not show neurophysiological defects or axon loss in peripheral nerves or in the epidermis of the hind paw or tail. Thus, despite the biochemical phenotype, the Sptlc1(C133W) mice do not show a strong neuropathy phenotype. Surprisingly, these mice were lethal as homozygotes, but the heterozygous genotype studied corresponds to the dominant genetics seen in humans. Thus, Yars(E196K) homozygous mice have a relevant phenotype, but imprecisely reproduce the human genetics, whereas the Sptlc1(C133W) mice precisely reproduce the human genetics, but do not recreate the disease phenotype. Despite these shortcomings, both models are informative and will be useful for future research.
引用
收藏
页码:1169 / 1185
页数:17
相关论文
共 50 条
  • [31] Overview of Charcot-Marie-Tooth disease type 1A
    Thomas, PK
    CHARCOT-MARIE-TOOTH DISORDERS, 1999, 883 : 1 - 5
  • [32] Early- onset severe hereditary sensory and autonomic neuropathy type 1 with S331F SPTLC1 mutation
    Suh, Bum Chun
    Hong, Young Bin
    Nakhro, Khriezhanuo
    Nam, Soo Hyun
    Chung, Ki Wha
    Choi, Byung-Ok
    MOLECULAR MEDICINE REPORTS, 2014, 9 (02) : 481 - 486
  • [33] Molecular genetics of the intermediate type of Charcot-Marie-Tooth disease
    Timmerman, V
    Verhoeven, K
    Nelis, E
    Ceuterick, C
    De Vriendt, E
    Jacobs, A
    Van Gerwen, V
    Smouts, I
    Martin, JJ
    Van Broeckhoven, C
    De Jonghe, P
    ACTA NEUROPATHOLOGICA, 2002, 104 (05) : 571 - 571
  • [34] Clinical and genetic study of the SPTLC1 gene mutation in patients with hereditary sensory neuropathy type 1
    Mourad, H.
    Fael, W.
    JOURNAL OF NEUROLOGY, 2008, 255 : 76 - 76
  • [35] Motor and sensory neuropathy due to myelin infolding and paranodal damage in a transgenic mouse model of Charcot-Marie-Tooth disease type 1C
    Lee, Samuel M.
    Sha, Di
    Mohammed, Anum A.
    Asress, Seneshaw
    Glass, Jonathan D.
    Chin, Lih-Shen
    Li, Lian
    HUMAN MOLECULAR GENETICS, 2013, 22 (09) : 1755 - 1770
  • [36] Sleep disorders in Charcot-Marie-Tooth disease type 1
    Boentert, Matthias
    Knop, Katharina
    Schuhmacher, Christine
    Gess, Burkhard
    Okegwo, Angelika
    Young, Peter
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (03): : 319 - 325
  • [37] A Rasch Analysis of the Charcot-Marie-Tooth Neuropathy Score (CMTNS) in a Cohort of Charcot-Marie-Tooth Type 1A Patients
    Wang, Wenjia
    Guedj, Mickael
    Bertrand, Viviane
    Foucquier, Julie
    Jouve, Elisabeth
    Commenges, Daniel
    Proust-Lima, Cecile
    Murphy, Niall P.
    Blin, Olivier
    Magy, Laurent
    Cohen, Daniel
    Attarian, Shahram
    PLOS ONE, 2017, 12 (01):
  • [38] Vestibular impairment in Charcot-Marie-Tooth type 1A and Hereditary Neuropathy with Liability to Pressure Palsies
    Calic, Z.
    Bjelica, B.
    Peric, S.
    Vujnic, M.
    Bozovic, I.
    Rakocevic-Stojanovic, V.
    Welgampola, M.
    Bradshaw, A.
    Welgampola, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 426 - 426
  • [39] Concurrence of Dystonia 1 and Charcot-Marie-Tooth Neuropathy, Type 1 A, in a Large Family
    Zirn, Birgit
    Korenke, Christoph
    Wagner, Michael
    Rudnik-Schoeneborn, Sabine
    Mueller, Ulrich
    MOVEMENT DISORDERS, 2011, 26 (02) : 361 - 362
  • [40] Quality of life in hereditary neuropathy with liability to pressure palsies is as impaired as in Charcot-Marie-Tooth disease type 1A
    Bjelica, B.
    Peric, S. Z.
    Bozovic, I.
    Basta, I.
    Kacar, A.
    Jankovic, M.
    Brankovic, M.
    Palibrk, A.
    Novakovic, I.
    Lavrnic, D.
    Stevic, Z.
    Stojanovic, V. Rakocevic
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 400 - 400